Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis (Q34529405)

2 August 2017

Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

2 August 2017

0 references

1 reference

Gail H Marracci

1

1 reference

2 August 2017

Richard E Jones

series ordinal

2

1 reference

2 August 2017

Gabriel P McKeon

series ordinal

3

1 reference

2 August 2017

Dennis N Bourdette

series ordinal

4

1 reference

2 August 2017

language of work or name

1 reference

1 October 2002

1 reference

Journal of Neuroimmunology

2 August 2017

1 reference

2 August 2017

131

1 reference

2 August 2017

1-2

1 reference

2 August 2017

104-114

1 reference

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

The pharmacology of the antioxidant lipoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Basic protein-specific T-cell lines that induce experimental autoimmune encephalomyelitis in SJL/J mice: comparison with Lewis rat lines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Effect of erythromycin on matrix metalloproteinase-9 and cell migration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Quantitative zymography: detection of picogram quantities of gelatinases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Inflammatory events at the blood brain barrier: regulation of adhesion molecules, cytokines, and chemokines by reactive nitrogen and oxygen species

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

alpha-Lipoic acid as a biological antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Extracellular matrix-degrading proteinases in the nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Determination of lipoic acid in human plasma by high-performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Reactive oxygen species are required for the phagocytosis of myelin by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Neuroprotective effects of alpha-lipoic acid and its enantiomers demonstrated in rodent models of focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Interferon beta in the treatment of multiple sclerosis: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900269-2

7 January 2021

10.1016/S0165-5728(02)00269-2

Identifiers

DOI

1 reference

2 August 2017

1 reference